Menu
GeneBe

HAX1

HCLS1 associated protein X-1

Basic information

Region (hg38): 1:154272354-154275875

Links

ENSG00000143575NCBI:10456OMIM:605998HGNC:16915Uniprot:O00165AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Kostmann syndrome (Definitive), mode of inheritance: AR
  • Kostmann syndrome (Strong), mode of inheritance: AR
  • Kostmann syndrome (Supportive), mode of inheritance: AR
  • Kostmann syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neutropenia, severe congenital, 3ARAllergy/Immunology/Infectious; OncologicIndividuals manifest with findings including susceptibility to severe bacterial infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Use of G-CSF has been reported, as well as treatment with BMT; Surveillance for malignancies may allow early detection and treatment, as there is an increased risk of manifestations such as acute myeloid leukemia and myelodysplastic syndromeAllergy/Immunology/Infectious; Audiologic/Otolaryngologic; Neurologic; Oncologic13326376; 17187068; 18337561; 21108402

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HAX1 gene.

  • Kostmann syndrome (301 variants)
  • not provided (29 variants)
  • not specified (24 variants)
  • Inborn genetic diseases (14 variants)
  • Severe congenital neutropenia (4 variants)
  • HAX1-related condition (2 variants)
  • Hereditary insensitivity to pain with anhidrosis (1 variants)
  • Neutropenia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HAX1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
94
clinvar
94
missense
92
clinvar
3
clinvar
95
nonsense
10
clinvar
2
clinvar
1
clinvar
13
start loss
0
frameshift
13
clinvar
2
clinvar
15
inframe indel
9
clinvar
2
clinvar
11
splice donor/acceptor (+/-2bp)
1
clinvar
9
clinvar
10
splice region
4
20
24
non coding
7
clinvar
41
clinvar
6
clinvar
54
Total 24 13 109 140 6

Highest pathogenic variant AF is 0.0000723

Variants in HAX1

This is a list of pathogenic ClinVar variants found in the HAX1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-154272574-A-T Kostmann syndrome Uncertain significance (Jan 12, 2018)292699
1-154272666-T-G Kostmann syndrome Benign (Jul 08, 2021)292700
1-154272666-TC-T Severe congenital neutropenia Likely benign (Jun 14, 2016)292701
1-154272670-CCG-C Benign (Mar 03, 2015)1290913
1-154272671-CG-T Benign (Mar 03, 2015)1260665
1-154272672-G-T Kostmann syndrome Benign (Jan 12, 2018)292702
1-154272719-C-T not specified Likely benign (Sep 11, 2019)1337365
1-154272732-C-G Kostmann syndrome Likely benign (Oct 13, 2020)1124819
1-154272732-C-T Kostmann syndrome Likely benign (Apr 10, 2021)1541241
1-154272732-CTT-C Kostmann syndrome Pathogenic (Oct 04, 2023)3002493
1-154272734-T-C Kostmann syndrome Uncertain significance (Apr 14, 2022)651979
1-154272735-T-C Kostmann syndrome Likely benign (Apr 14, 2023)1653775
1-154272737-A-C Kostmann syndrome Uncertain significance (Aug 30, 2021)476636
1-154272738-T-A Kostmann syndrome Uncertain significance (Oct 28, 2022)863374
1-154272738-TC-T Kostmann syndrome Pathogenic (Apr 22, 2023)2858293
1-154272741-C-G Kostmann syndrome Likely benign (Dec 30, 2023)1102743
1-154272741-C-T Kostmann syndrome • HAX1-related disorder Likely benign (Dec 18, 2023)1145111
1-154272744-C-T Kostmann syndrome Likely benign (Sep 05, 2021)1092301
1-154272747-G-A Kostmann syndrome Likely benign (Apr 06, 2023)2164904
1-154272750-C-T Kostmann syndrome Likely benign (Dec 12, 2021)2040973
1-154272753-T-C Kostmann syndrome Likely benign (Sep 08, 2023)1091873
1-154272755-T-C Kostmann syndrome Uncertain significance (Jul 15, 2022)2004543
1-154272759-C-G Kostmann syndrome Likely benign (Jan 01, 2024)743330
1-154272765-T-G Kostmann syndrome Likely benign (Mar 31, 2023)2167715
1-154272766-G-T Kostmann syndrome Pathogenic (Jun 14, 2023)2715418

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HAX1protein_codingprotein_codingENST00000328703 73365
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.48e-80.30312564001081257480.000430
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1361581630.9700.000009731855
Missense in Polyphen3447.9960.70839604
Synonymous0.7944956.60.8660.00000304539
Loss of Function0.5231214.10.8508.47e-7142

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008280.000821
Ashkenazi Jewish0.0006950.000695
East Asian0.0007610.000761
Finnish0.00009240.0000924
European (Non-Finnish)0.0005810.000580
Middle Eastern0.0007610.000761
South Asian0.00006530.0000653
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex (PubMed:26997484). Slows down the rate of inactivation of KCNC3 channels (PubMed:26997484). Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools. {ECO:0000269|PubMed:15339924, ECO:0000269|PubMed:16857965, ECO:0000269|PubMed:17545607, ECO:0000269|PubMed:18319618, ECO:0000269|PubMed:18971376, ECO:0000269|PubMed:26997484, ECO:0000269|PubMed:9058808}.;
Disease
DISEASE: Neutropenia, severe congenital 3, autosomal recessive (SCN3) [MIM:610738]: A disorder of hematopoiesis characterized by maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 10(9)/l and early onset of severe bacterial infections. Some patients affected by severe congenital neutropenia type 3 have neurological manifestations such as psychomotor retardation and seizures. {ECO:0000269|PubMed:17187068, ECO:0000269|PubMed:18337561, ECO:0000269|PubMed:19796188, ECO:0000269|PubMed:20220065}. Note=The disease is caused by mutations affecting the gene represented in this entry. The clinical phenotype due to HAX1 deficiency appears to depend on the localization of the mutations and their influence on the transcript variants. Mutations affecting exclusively isoform 1 are associated with isolated congenital neutropenia, whereas mutations affecting both isoform 1 and isoform 5 are associated with additional neurologic symptoms (PubMed:18337561). {ECO:0000269|PubMed:18337561}.;

Recessive Scores

pRec
0.205

Intolerance Scores

loftool
0.976
rvis_EVS
-0.56
rvis_percentile_EVS
19.31

Haploinsufficiency Scores

pHI
0.133
hipred
N
hipred_score
0.394
ghis
0.599

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.967

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hax1
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
mitochondrion organization;positive regulation of phosphatidylinositol 3-kinase signaling;regulation of actin filament polymerization;positive regulation of granulocyte differentiation;positive regulation of peptidyl-serine phosphorylation;regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of protein kinase B signaling;cellular response to cytokine stimulus;regulation of autophagy of mitochondrion;regulation of protein targeting to mitochondrion;positive regulation of actin cytoskeleton reorganization
Cellular component
P-body;nuclear envelope;transcription factor complex;mitochondrion;mitochondrial outer membrane;mitochondrial intermembrane space;endoplasmic reticulum;plasma membrane;cell cortex;actin cytoskeleton;sarcoplasmic reticulum;lamellipodium;cytoplasmic vesicle;nuclear membrane
Molecular function
protein binding;interleukin-1 binding;protein N-terminus binding